Ghost Tree Capital, LLC Apellis Pharmaceuticals, Inc. Call Options Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$37.14 - $64.82 $3.16 Million - $5.51 Million	-85,000 Reduced 45.95%	100,000 $5.99 Million
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $4.38 Million - $16.5 Million	185,000 New	185,000 $7.04 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $2.42 Million - $3.48 Million	51,900 New	51,900 $3.42 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $4.71 Million - $10.5 Million	150,000 New	150,000 $4.94 Million
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $4.48 Million - $11.1 Million	-250,000 Closed	0 $0
Q4 2019 Apr 09, 2020	BUY	$22.1 - $30.8 $5.53 Million - $7.7 Million	250,000 New	250,000 $7.66 Million

308

115M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.89B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.